Johnson & Johnson announced sales of $20.8 billion in the second quarter of 2018, an increase of 10.6% from 2017’s second quarter totals, according to a company press release.
Net earnings for the quarter were $4 billion, or $1.45 per diluted share, which included an after-tax intangible amortization expense of about $1 billion, as well as a charge for after-tax special items of $0.8 billion, the release said.
Adjusted net earnings for the quarter, excluding the amortization expense and special items, were $5.7 billion, or $2.10 per share.
The company’s (Read more...)
Uncategorized